-
Neurology: gradual freezing syndrome, abnormal eye movements or predictable cognitive changes
Time of Update: 2021-09-29
However, in ALS patients, the frequency of clinically significant OMAs found through standard neurological examinations rather than quantitative video oculographic measurements , and their relationship to underlying motor and cognitive phenotypes are still unknown .
-
Mov Disord: In the mentally related symptoms of Parkinson's patients, the serotonin and dopamine production system is the "culprit"?
Time of Update: 2021-09-29
They conducted a cross-sectional study that combined clinical and dual-tracer positron emission tomography (PET) neuroimaging methods, using dopamine radioligand ([11 C]DASB) reuptake, in different courses of Pa Among patients with Kinsen's disease (ie short course of disease without medicine (n = 27, 0-2 years course), with apathy (n = 14) or none (n = 13); moderate course (n = 15, 4) -7 years disease course) and long disease course, patients without dementia (n=15, 8-10 years disease course)) .
-
Mov Disord: The later the menopause, the lower the prevalence of Parkinson's disease
Time of Update: 2021-09-29
In observational studies, the relationship between the life-long level of female sex hormones and PD was extensively explored through alternative measures of self-reported menarche age and menopausal age .
-
JAMA Neurology: Parkinson, deep brain stimulation, general anesthesia or local anesthesia, which one is better?
Time of Update: 2021-09-29
Holewijn and others of the University of Amsterdam reported the results of a randomized clinical trial of general anesthesia and stereotactic local anesthesia (GALAXY), which aims to compare the subthalamic nucleus DBS operation under general anesthesia and local anesthesia For surgery, both groups used stereotactic frame-based MRI and microelectrode recording to determine the target .
-
Stroke: What is the outcome of endovascular treatment for dyskinesia before stroke?
Time of Update: 2021-09-29
In this way, Rachel Beekman and others of Yale University used this large national stroke register to describe the frequency of pre-stroke mobility impairment (PSMI) in the real world in patients receiving EVT treatment .
-
Mov Disord: What is the current incidence of Parkinson's disease in China?
Time of Update: 2021-09-29
Subsequently, a study conducted in three major cities (Beijing in the northeast, Xi'an in the northwest, and Shanghai in the southeast) from 1997 to 1998 showed that the prevalence of PD among residents 65 years of age or older was 1.
-
JAMA Neuro: "Magic Oil" immunotherapy is really omnipotent!
Time of Update: 2021-09-29
The data currently available indicate that immunotherapy has been proven to improve the prognosis of patients with N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis (NMDARE) and reduce recurrence; therefore, immunotherapy has become the first line of clinical practice Treatment plan .
-
World Alzheimer's Day | How to prevent incurable diseases?
Time of Update: 2021-09-29
Development, patients with amnesia, dementia, disability, and abnormal mental behavior, the condition may last 8-20 years, the cause of the disease is complicated, and there is no cure at present, but it can delay the development of the condition and improve the patient through drugs, rehabilitation, etc.
-
Stroke: The significance of iron deposits on the cerebellar surface in cerebral amyloid angiopathy
Time of Update: 2021-09-29
The study aims to investigate the frequency of iron deposition on the cerebellar surface of patients with sporadic and Dutch hereditary CAA and patients with deep penetrating artery disease-related intracerebral hemorrhage and its relationship with hemorrhagic The relationship between MRI markers .
-
Mov Disord: neurofilament light chain, can predict cognitive decline in patients with Parkinson's
Time of Update: 2021-09-29
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease .
28779Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease in this message
-
Neurology: Epidemiology of the treatment of epilepsy in children in New Zealand: focus on race
Time of Update: 2021-09-29
A review of the NZ Pharmaceutical Collection database covering approximately 48% of the pediatric population in New Zealand in 2015 was carried out, and anti-epileptic drug (ASM) drug records were searched for ≤18 years of age, and medical records of confirmed cases were reviewed to determine the prescription of ASM.
-
Neurology: What is the quality of sleep for migraine patients?
Time of Update: 2021-09-29
Compared with healthy people, the subjective sleep quality of migraine patients is significantly worse, and the sleep structure has also changedOriginal source: Stanyer EC, Creeney H, Nesbitt AD, Robert Holland PR, Hoffmann J.
-
Neurology: Long-term risk of persistent CSF leakage from the ventral spinal cord in SIH patients: superficial ironosis and arm muscular atrophy
Time of Update: 2021-09-29
In patients with SIH and persistent cerebrospinal fluid leakage from the ventral spinal cord, the risk of developing severe long-term sequelae is considerable .
In patients with SIH and persistent cerebrospinal fluid leakage from the ventral spinal cord, the risk of developing severe long-term sequelae is considerable .
-
Neurology: The relationship between clinically obvious eye movement abnormalities and motor and cognitive characteristics in patients with motor neuron disease
Time of Update: 2021-09-29
Video Recently, researchers have observed the frequency of OMA in patients with ALS, determined the corresponding OMA pattern, and analyzed its association with sports and cognitive behavioral characteristics .
-
Neurology: What is the progress and prognosis of inflammation associated with cerebral amyloid angiopathy?
Time of Update: 2021-09-29
These results from the largest longitudinal cohort registration of CAA-ri patients support the transient and potentially recurrent inflammatory nature of the clinical-radiological acute manifestations of the disease , and the effectiveness of slow oral dose reduction after intravenous corticosteroid pulse therapy in preventing recurrence Sex .
-
Mov Disord: Subcutaneous injection of a new drug of levodopa to treat Parkinson's, how effective
Time of Update: 2021-09-29
The important significance of this study lies in: The subcutaneous injection of levodopa/carbidopa continuous infusion of ND0612 is generally safe, and the typical infusion site reaction of SC administration is the main adverse event .
-
Mov Disord: Bipolar disorder makes Parkinson "worse worse"
Time of Update: 2021-09-29
BSD, as a prodromal symptom of PD, is not conducive to the development of its course, and is related to harmful neuropsychiatric characteristics and treatment results .
-
Mov Disord: Xiangya Hospital: Neurofilament light chain protein can effectively predict ataxia
Time of Update: 2021-09-29
However, a comprehensive meta-analysis has not been conducted to evaluate the potential role of NfL as a biomarker in predicting the occurrence of disease or symptoms, measuring disease severity, tracking disease progression, and monitoring treatment response to genetic ataxia .
-
Mov Disord: A new type of levodopa intestinal gel, which can effectively slow down the performance of Parkinson’s dyskinesias
Time of Update: 2021-09-29
tensionIn this way, Eric Freire-Alvarez of the University General Hospital of Elche, Spain, and others conducted a 12-week randomized study in patients with advanced Parkinson’s disease to evaluate LCIG and OMT in dyskinesias through UdysRS and Parkinson’s disease diary.
-
Stroke: The basis of chronic diseases, or explain the differences in the prognosis of stroke in different races
Time of Update: 2021-09-29
The purpose of this study is to use the new MCC index to understand the contribution of MCC to the racial difference in FO within 90 days of MA and NHW ischemic stroke patients .